Wednesday, April 27, 2016| , Alcon, , Alcon Laboratories, , Cataract Surgery, , Valeant,

EyewireTV - Alcon Invests in New IOL Technology; Bilateral Cataract Surgery Debated

In this week’s EyewireTV, Alcon enters into a strategic alliance with PowerVision in which Alcon will provide funding for the clinical development of PowerVision's fluid-based IOL technology; and Valeant Pharmaceuticals names Joseph C. Papa as chairman and CEO, replacing J. Michael Pearson. Also, three leading ophthalmologists share their opinions on the practicality of bilateral cataract surgery, and whether they would be open to adopting it more regularly into their practice. (3915 Views)

Watch Video

Wednesday, April 20, 2016

EyewireTV — CXL Approved by FDA; New Femto Cannula Launched

In this week’s EyewireTV, Avedro receives FDA approval for Photrexa Viscous, Photrexa, and the KXL System for corneal collagen cross-linking in patients with progressive keratoconus; and 12-month data highlight the safety and efficacy of ab interno canaloplasty for primary open-angle glaucoma. Also, Beaver-Visitec International launches a multifunctional cannula designed to improve surgical efficiency and optimize clinical outcomes during laser cataract surgery. (3548 Views)

Watch Video

Wednesday, April 13, 2016

EyewireTV - BromSite Approved; Ridley Innovation Centre Unveiled

In this week's EyewireTV, Sun Pharma receives FDA approval for BromSite, the first NSAID indicated for the prevention of ocular pain and treatment of postoperative inflammation in patients undergoing cataract surgery; and researchers at the USC Roski Eye Institute publish results from the largest eye study ever conducted in Chinese Americans. Also, Rayner unveils the Ridley Innovation Centre, a state-of-the-art research and development, training, and production facility with the capability of manufacturing 3 million IOLs per year. (3193 Views)

Watch Video

Wednesday, April 06, 2016| , Acquisitions, Mergers, , Allergan, , American Society of Cataract & Ref Surgeons, ASCRS, , Corneal Collagen Crosslinking, CXL, , Corneal Ectasia, , FDA Approval/Clearance, , Keratoconus, , Pfizer, , Refractive Surgery, , Taxes,

EyewireTV - Pfizer and Allergan Call Off Blockbuster Deal

In this week’s EyewireTV, Pfizer and Allergan decide to call off their planned $160 billion merger after the Treasury Department unveiled a series of new steps to curb tax inversions; and the FDA is expected to decide in the next 10 days whether or not to approve corneal collagen cross-linking in the UnitedStates for the treatment for progressive keratoconus and corneal ectasia following refractive surgery. Also, the American Society of Cataract and Refractive Surgery forms the ASCRS Research Council, an internal department that will collaborate with members and partners on research trials. (3509 Views)

Watch Video

Wednesday, March 30, 2016| , branded vs. generics, , Teleophthalmology,

EyewireTV - Concussion Eye Test Approved; Branded vs Generic Drugs

In this week's EyewireTV, Eye-Sync, a mobile device that assesses abnormal eye movement—a common deficit after a concussion—receives FDA clearance; and a new study shows that teleophthalmology may play a role in reducing coverage gaps in emergency department eye care, particularly in rural areas. In the feature, physicians discuss how important it is to prescribe branded versus generic medications and, if branded drugs are a priority, how they communicate that to the patient, who will most likely be paying a higher cost out of pocket. (2658 Views)

Watch Video

Wednesday, March 23, 2016

EyewireTV - Valeant Management Shakeup; Cataract Progression: Diet vs. Genetics

In this week’s EyewireTV, in a major management shakeup, Valeant Pharmaceuticals announces a series of executive changes; and a large study shows for the first time that diet and lifestyle may play a greater role than genetics in cataract development and severity. Also, InnoVision Labs launches a mobile app designed to improve image processing speed, depth perception, vision sharpness, and contrast sensitivity. (3652 Views)

Watch Video

Wednesday, March 16, 2016| , Allergan, , Cataract,

EyewireTV - Cataract Surgery Using Stem Cells; 1-Year Raindrop Inlay Results

In this week’s EyewireTV, researchers in California and China have developed a new cataract treatment for infants that uses their own stem cells to regrow functional lenses; and Allergan is being asked by the FDA to provide additional information for its new multi-dose, preservative-free form of Restasis. Also, 1-year data from a phase 3 clinical trial of the Raindrop Near Vision Inlay show improved near visual performance and a 92% rate of satisfaction. (4754 Views)

Watch Video

Wednesday, March 09, 2016| , FDA Approval/Clearance, , Glaucoma, , Ophthalmic viscosurgical device, OVD, , Phacoemulsification, , Rayner Intraocular Lenses, , Retinitis pigmentosa, , Sensimed,

EyewireTV - Smart Contact Lens Cleared by FDA; New Epiretinal Implant

In this week’s EyewireTV, the Sensimed Triggerfish electronic contact lens, a device that senses eye pressure changes in glaucoma patients, receives FDA clearance; and Pixium Vision announces the first implant and successful activation of the IRIS II, an epiretinal implant intended for patients who have lost sight due to retinitis pigmentosa. Also, Rayner launches a new ophthalmic viscosurgical device, Ophteis FR Pro, indicated to protect the corneal endothelium from free radical energy caused by phacoemulsification. (6427 Views)

Watch Video

Wednesday, March 02, 2016| , Anti-VEGF, , Diabetic macular edema, DME, , Diabetic Retinopathy,

EyewireTV - Protocol T 2-Year Results; AECOS Eye Charities

In this week’s EyewireTV, 2-year results of the Diabetic Retinopathy Clinical Research Network Protocol T study comparing three anti-VEGF agents used to treat diabetic macular edema are released; and several management and leadership announcements are made in the eye care market. Also, attendees of the AECOS Winter Symposium in Aspen, Colorado, share what their favorite eye charity or charitable cause is. (4192 Views)

Watch Video

Wednesday, February 24, 2016| , Aerie Pharmaceuticals, , Alcon, , Glaucoma, , MIGS, , Ocular Hypertension, OHT, , Ocular Therapeutix, , Transcend Medical,

EyewireTV - Alcon Now a MIGS Player; Glaucoma Product Advancements

In this week's EyewireTV, Alcon enters the growing MIGS market after it agrees to acquire Transcend Medical, maker of the CyPass micro-stent; and Aerie Pharmaceuticals reports 12-month interim safety results of Rocket 2, the second phase 3 registration trial for glaucoma drug candidate Rhopressa (netarsudil ophthalmic solution 0.02%). Also, Ocular Therapeutix announces a new phase 3 clinical development strategy for OTX-TP (sustained-release travoprost) for the treatment of glaucoma and ocular hypertension. (3246 Views)

Watch Video

Wednesday, February 17, 2016| , Argus II, , Optovue, , Second Sight Medical Products,

EyewireTV - FDA Clears OCT Angiography Device; Long-Term Argus II Results

In this week’s EyewireTV, Optovue announces FDA 510(k) clearance of the AngioVue Imaging System, which provides a noninvasive way to visualize abnormal blood vessels in the retina; and Second Sight Medical Products announces the results of a 3-year study evaluating the functional visual abilities of patients using the Argus II retinal prothesis system. In the feature, three leading ophthalmologists discuss the process of engaging conversations, and explaining technology and lens options, with patients pre- and postopertively. (3528 Views)

Watch Video

Wednesday, February 10, 2016| , Glaucoma, , Myopia,

EyewireTV — Glaucoma Progression Contact Lens; Childhood Myopia On The Rise

In this week’s EyewireTV, a new study shows that the Sensimed Triggerfish contact lens system may help determine which glaucoma patients have a higher risk of disease progression; and in what researchers are calling the largest study of childhood eye diseases ever undertaken in the United States, the USC Eye Institute reports a significant increase in childhood myopia. Also, Oculus receives 510(k) clearance from the FDA for the Pentacam AXL anterior segment tomography device. (3466 Views)

Watch Video
Load More